Fetal hydantoin syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 17: Line 17:
{{CMG}}
{{CMG}}


{{SK}} congenital hydantoin syndrome; Fetal Hydantoin Syndrome; Dilantin Embryopathy; Phenytoin Embryopathy;  
{{SK}} Congenital hydantoin syndrome; Fetal Hydantoin Syndrome; Dilantin Embryopathy; Phenytoin Embryopathy; Fetal dilantin syndrome


==Overview==
==Overview==
'''Fetal hydantoin syndrome''', also called '''fetal dilantin syndrome''' is a group of defects caused to the developing fetus by exposure to the teratogenic effects of [[phenytoin]]. Dilantin is the [[brand name]] of the drug phenytoin sodium in the [[United States]], commonly used in the treatment of [[epilepsy]].
'''Fetal hydantoin syndrome''' is a group of defects caused to the developing fetus by exposure to the teratogenic effects of [[phenytoin]]. Dilantin is the [[brand name]] of the drug phenytoin sodium in the [[United States]], commonly used in the treatment of [[epilepsy]].


Association with [[EPHX1]] has been suggested.<ref>{{OMIM|132810}}</ref>
Association with [[EPHX1]] has been suggested.<ref>{{OMIM|132810}}</ref>

Revision as of 20:29, 30 July 2012

Fetal hydantoin syndrome
Phenytoin
ICD-10 Q86.1
ICD-9 760.77
OMIM 132810
DiseasesDB 33179

WikiDoc Resources for Fetal hydantoin syndrome

Articles

Most recent articles on Fetal hydantoin syndrome

Most cited articles on Fetal hydantoin syndrome

Review articles on Fetal hydantoin syndrome

Articles on Fetal hydantoin syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Fetal hydantoin syndrome

Images of Fetal hydantoin syndrome

Photos of Fetal hydantoin syndrome

Podcasts & MP3s on Fetal hydantoin syndrome

Videos on Fetal hydantoin syndrome

Evidence Based Medicine

Cochrane Collaboration on Fetal hydantoin syndrome

Bandolier on Fetal hydantoin syndrome

TRIP on Fetal hydantoin syndrome

Clinical Trials

Ongoing Trials on Fetal hydantoin syndrome at Clinical Trials.gov

Trial results on Fetal hydantoin syndrome

Clinical Trials on Fetal hydantoin syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Fetal hydantoin syndrome

NICE Guidance on Fetal hydantoin syndrome

NHS PRODIGY Guidance

FDA on Fetal hydantoin syndrome

CDC on Fetal hydantoin syndrome

Books

Books on Fetal hydantoin syndrome

News

Fetal hydantoin syndrome in the news

Be alerted to news on Fetal hydantoin syndrome

News trends on Fetal hydantoin syndrome

Commentary

Blogs on Fetal hydantoin syndrome

Definitions

Definitions of Fetal hydantoin syndrome

Patient Resources / Community

Patient resources on Fetal hydantoin syndrome

Discussion groups on Fetal hydantoin syndrome

Patient Handouts on Fetal hydantoin syndrome

Directions to Hospitals Treating Fetal hydantoin syndrome

Risk calculators and risk factors for Fetal hydantoin syndrome

Healthcare Provider Resources

Symptoms of Fetal hydantoin syndrome

Causes & Risk Factors for Fetal hydantoin syndrome

Diagnostic studies for Fetal hydantoin syndrome

Treatment of Fetal hydantoin syndrome

Continuing Medical Education (CME)

CME Programs on Fetal hydantoin syndrome

International

Fetal hydantoin syndrome en Espanol

Fetal hydantoin syndrome en Francais

Business

Fetal hydantoin syndrome in the Marketplace

Patents on Fetal hydantoin syndrome

Experimental / Informatics

List of terms related to Fetal hydantoin syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords: Congenital hydantoin syndrome; Fetal Hydantoin Syndrome; Dilantin Embryopathy; Phenytoin Embryopathy; Fetal dilantin syndrome

Overview

Fetal hydantoin syndrome is a group of defects caused to the developing fetus by exposure to the teratogenic effects of phenytoin. Dilantin is the brand name of the drug phenytoin sodium in the United States, commonly used in the treatment of epilepsy.

Association with EPHX1 has been suggested.[1]

Prevalence and presentation

About one third of children whose mothers are taking this drug during pregnancy typically have intrauterine growth restriction with microcephaly and develop minor dysmorphic craniofacial features and limb defects including hypoplastic nails and distal phalanges (birth defects). A smaller population will have growth problems and developmental delay, or mental retardation. Rare side effects include methemoglobinemia.

Heart defects[citation needed] and cleft lip[2] may also be featured.

References

  1. Online Mendelian Inheritance in Man (OMIM) 132810
  2. Easton JD (1972). "Potential hazards of hydantoin use". Ann. Intern. Med. 77 (6): 998–9. PMID 4644176. Unknown parameter |month= ignored (help)

Template:Congenital malformation due to exogenous toxicity